SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-275594
Filing Date
2021-09-17
Accepted
2021-09-17 07:07:59
Documents
18
Period of Report
2021-09-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d203720d8k.htm   iXBRL 8-K 33811
2 EX-99.1 d203720dex991.htm EX-99.1 43367
3 EX-99.2 d203720dex992.htm EX-99.2 19829
4 EX-99.3 d203720dex993.htm EX-99.3 12648
8 GRAPHIC g203720dsp001.jpg GRAPHIC 295870
9 GRAPHIC g203720g32c40.jpg GRAPHIC 5536
10 GRAPHIC g203720page001.jpg GRAPHIC 303401
  Complete submission text file 0001193125-21-275594.txt   1093348

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dcph-20210917.xsd EX-101.SCH 2894
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20210917_lab.xml EX-101.LAB 17373
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20210917_pre.xml EX-101.PRE 10954
11 EXTRACTED XBRL INSTANCE DOCUMENT d203720d8k_htm.xml XML 3227
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 211259222
SIC: 2834 Pharmaceutical Preparations